Data collection is paused while the tracker is being upgraded. The data below is complete up to 20 August 2026.

BioMed Partners

Switzerland · 19 portfolio companies

Portfolio

CompanySectorStageCountry
ALENTIS Therapeutics AG and SAS Switzerland, France
AMAL Therapeutics SA Switzerland
Allecra Therapeutics GmbH BiotechFrance, Germany
Azafaros B.V. Netherlands
Cardior Pharmaceuticals GmbH Germany
Dimericon Therapeutics Switzerland
ImmunOs Therapeutics AG BiotechSwitzerland
NXI Therapeutics Switzerland
Noema Pharma AG BiotechSwitzerland
OmnilinX Therapeutics AG Switzerland
PRECIRIX NV BiotechBelgium
Salvina Therapeutics AG Switzerland
Scenic Biotech B.V. BiotechNetherlands
T-CURX GmbH Germany
TOLREMO Therapeutics AG Switzerland
TRiCares GmbH and SAS Medtech, HealthtechFrance, Germany, Brazil
Topas Therapeutics Germany
Tubulis GmbH BiotechGermany
iDEL Therapeutics GmbH Germany

Recorded changes

No recorded changes.

Spotted something wrong? Tell us.